Ligand Reports First Quarter 2021 Financial Results
Go back to Ligand Reports First Quarter 2021 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 302.57 +1.78 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $300.79 | 52 Week High | $139.79 | |||
| Open | $305.26 | 52 Week Low | $82.07 | |||
| Day High | $308.56 | P/E | 703.65 | |||
| Day Low | $300.07 | EPS | $0.43 | |||
| Volume | 197,093 | |||||

